Contract 75N93018C00025
Access To Advanced Health Institute · Department Of Health And Human Services · August 5, 2024
Access To Advanced Health Institute was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 5, 2024 for $11.26 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Seattle, WA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost-plus contract pricing. The most recent modification was on December 10, 2025. If all options are exercised, the contract could reach $18.84 million.
Contract details
- PIID
- 75N93018C00025
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Seattle, WA
- First action
- August 5, 2024
- Latest action
- December 10, 2025
Description
THE PURPOSE OF THIS CONTRACT IS TO ENABLE ADVANCED PRECLINICAL DEVELOPMENT OF AN INTRANASAL RECOMBINANT AMEBIASIS VACCINE CONTAINING A LIPOSOMAL ADJUVANT FORMULATION OF CLINICAL TLR4 AND TLR7/8 LIGANDS.
Modification timeline
-
December 10, 2025Mod P00019 · Supplemental Agreement For Work Within Scope$11.26M
-
July 1, 2025Mod P00018 · Other Administrative Action$11.26M
-
August 5, 2024Mod P00014 · Supplemental Agreement For Work Within Scope$11.26M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93018C00025?
Contract 75N93018C00025 is a federal contract awarded to Access To Advanced Health Institute by Department Of Health And Human Services on August 5, 2024 for $11.26 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75N93018C00025?
Access To Advanced Health Institute won contract 75N93018C00025 from Department Of Health And Human Services.
How much is contract 75N93018C00025 worth?
Contract 75N93018C00025 has obligated $0 to date but carries a potential ceiling of $18.84 million if fully funded and all options are exercised.